Simcere Pharmaceutical Co., Ltd
Clinical trials sponsored by Simcere Pharmaceutical Co., Ltd, explained in plain language.
-
New drug shows promise for lupus kidney disease in early trial
Disease control Not yet recruitingThis study tests a new medicine, SIM0278, in 60 adults with active lupus nephritis, a kidney problem caused by lupus. Half will get the drug, half a placebo, and researchers will check if it helps improve kidney function over 52 weeks. The goal is to see if the drug is safe and w…
Phase: PHASE2 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
Healthy volunteers to test new remdesivir formulation
Knowledge-focused Not yet recruitingThis study will compare two different versions of an oral remdesivir drug in 48 healthy Chinese adults. Participants will receive both forms at different times to see how the body absorbs and processes each one. The goal is to understand if the new formulation works similarly to …
Phase: PHASE1 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 18, 2026 12:12 UTC